Pierre-Michel L.
- Country
- France
- Department
- Service de Psychiatrie Adulte
Research Overview
- Phase III Multicenter Open-Label Trial Evaluating Rituximab Efficacy in Psychiatric Disorders with Autoimmunity
- Evaluation of Dose Reduction Versus Maintenance Treatment in Schizophrenia Spectrum Disorder Using Pipotiazine and Drug Combination
- Long-term Safety Evaluation of Trospium Chloride and Xanomeline Tartrate in Treating Mania or Mixed Features in Bipolar-I Disorder: A Phase 3 Open-label Extension Study
Data & Insights
Has run more than one trial at 24 of 56 partner sites.
Specializations
Psychiatric Disorders
The investigator specializes in the treatment and research of psychiatric disorders, with particular emphasis on schizophrenia and related psychotic conditions.
- Schizophrenia Management
- Psychotic Symptom Treatment
- Mental Health Disorders
The research focus includes evaluating innovative therapeutic approaches for psychiatric conditions.
Immunotherapy Applications
The investigator explores the intersection of immunology and psychiatry, studying the role of immunomodulatory therapy in mental health treatment.
- Autoimmune Mechanisms in Psychiatry
- Immunological Interventions
- Novel Treatment Approaches
Particular attention is given to cases where psychiatric disorders present with proven dysimmunity.
Treatment Innovation
The investigator conducts research on comparative therapeutic approaches and bioavailability assessments of psychiatric medications.
- Medication Efficacy Studies
- Alternative Treatment Methods
- Therapeutic Integration
Focus includes evaluation of both standard psychotropic treatments and innovative therapeutic combinations.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.